Canadian Sec - Delayed Quote CAD

C21 Investments Inc. (CXXI.CN)

0.2100
+0.0050
+(2.44%)
At close: 3:58:56 PM EDT
Loading Chart for CXXI.CN
  • Previous Close 0.2050
  • Open 0.2000
  • Bid 0.2100 x --
  • Ask 0.2150 x --
  • Day's Range 0.2000 - 0.2100
  • 52 Week Range 0.1500 - 0.5700
  • Volume 19,000
  • Avg. Volume 35,002
  • Market Cap (intraday) 24.779M
  • Beta (5Y Monthly) 2.57
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Jul 21, 2025 - Jul 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk, wholesale, and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. The company was incorporated in 1987 and is headquartered in Vancouver, Canada.

www.cxxi.ca

114

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CXXI.CN

View More

Performance Overview: CXXI.CN

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CXXI.CN
20.75%
S&P/TSX Composite index (^GSPTSE)
4.35%

1-Year Return

CXXI.CN
60.38%
S&P/TSX Composite index (^GSPTSE)
15.51%

3-Year Return

CXXI.CN
59.62%
S&P/TSX Composite index (^GSPTSE)
27.82%

5-Year Return

CXXI.CN
58.82%
S&P/TSX Composite index (^GSPTSE)
77.07%

Compare To: CXXI.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CXXI.CN

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    24.19M

  • Enterprise Value

    39.48M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.64

  • Price/Book (mrq)

    0.57

  • Enterprise Value/Revenue

    1.00

  • Enterprise Value/EBITDA

    12.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.67%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    26.79M

  • Net Income Avi to Common (ttm)

    -308.63k

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.5M

  • Total Debt/Equity (mrq)

    44.35%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CXXI.CN

View More

People Also Watch